VirtualScopics, Inc. 4

4 · VirtualScopics, Inc. · Filed May 12, 2016

Form 4

Period: 2016-05-10

Director

Transactions

Disposition to Issuer
Stock Options
2016-05-10−1,485→ 0 total
Exercise: $10.20Exp: 2019-05-27→ Common Stock (1,485 underlying)
Disposition to Issuer
Common Stock
2016-05-10$4.05/sh−51,357$207,996→ 0 total
Disposition to Issuer
Stock Options
2016-05-10−1,172→ 0 total
Exercise: $12.80Exp: 2020-05-10→ Common Stock (1,172 underlying)
Disposition to Issuer
Stock Options
2016-05-10−1,000→ 0 total
Exercise: $19.90Exp: 2021-05-02→ Common Stock (1,000 underlying)
Disposition to Issuer
Stock Options
2016-05-10−1,500→ 0 total
Exercise: $12.10Exp: 2022-02-27→ Common Stock (1,500 underlying)
Disposition to Issuer
Stock Options
2016-05-10−500→ 0 total
Exercise: $8.60Exp: 2022-08-14→ Common Stock (500 underlying)
Disposition to Issuer
Series B Convertible Preferred Stock
2016-05-10$336.30/sh−100$33,630→ 0 total
Exercise: $336.30From: 2007-11-23→ Common Stock (100 underlying)

Footnotes (2)

[F1]These options which provided for vesting in four equal annual installments beginning 5/27/09, 5/10/10, 5/2/11, 2/27/12 and 8/14/12, respectively, were cancelled pursuant to a Merger Agreement between Issuer and BioTelemetry Research Acquisition Corporation, a wholly-owned subsidiary of BioTelemetry, Inc., in exchange for an amount in cash equal to the product of (A) the positive excess, if any, of (1) the Common Merger Consideration over (2) the exercise price per Common Share then in effect in respect of such stock option, and (B) the aggregate number of Common Shares subject to such stock option immediately prior to the effective time of the merger.
[F2]The Series B Convertible Preferred Stock does not expire.

Documents

1 file